Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy
Tóm tắt
The glucosuria induced by sodium–glucose cotransporter 2 (SGLT2) inhibition stimulates endogenous (hepatic) glucose production (EGP), blunting the decline in HbA1c. We hypothesised that, in response to glucosuria, a renal signal is generated and stimulates EGP. To examine the effect of acute administration of SGLT2 inhibitors on EGP, we studied non-diabetic individuals who had undergone renal transplant with and without removal of native kidneys. This was a parallel, randomised, double-blind, placebo-controlled, single-centre study, designed to evaluate the effect of a single dose of dapagliflozin or placebo on EGP determined by stable-tracer technique. We recruited non-diabetic individuals who were 30–65 years old, with a BMI of 25–35 kg/m2 and stable body weight (±2 kg) over the preceding 3 months, and HbA1c <42 mmol/mol (6.0%). Participants had undergone renal transplant with and without removal of native kidneys and were on a stable dose of immunosuppressive medications. Participants received a single dose of dapagliflozin 10 mg or placebo on two separate days, at a 5- to 14-day interval, according to randomisation performed by our hospital pharmacy, which provided dapagliflozin and matching placebo, packaged in bulk bottles that were sequentially numbered. Both participants and investigators were blinded to group assignment. Twenty non-diabetic renal transplant patients (ten with residual native kidneys, ten with bilateral nephrectomy) participated in the study. Dapagliflozin induced greater glucosuria in individuals with residual native kidneys vs nephrectomised individuals (8.6 ± 1.1 vs 5.5 ± 0.5 g/6 h; p = 0.02; data not shown). During the 6 h study period, plasma glucose decreased only slightly and similarly in both groups, with no difference compared with placebo (data not shown). Following administration of placebo, there was a progressive time-related decline in EGP that was similar in both nephrectomised individuals and individuals with residual native kidneys. Following dapagliflozin administration, EGP declined in both groups, but the differences between the decrement in EGP with dapagliflozin and placebo in the group with bilateral nephrectomy (Δ = 1.11 ± 0.72 μmol min−1 kg−1) was significantly lower (p = 0.03) than in the residual native kidney group (Δ = 2.56 ± 0.33 μmol min−1 kg−1). In the population treated with dapagliflozin, urinary glucose excretion was correlated with EGP (r = 0.34, p < 0.05). Plasma insulin, C-peptide, glucagon, prehepatic insulin:glucagon ratio, lactate, alanine and pyruvate concentrations were similar following placebo and dapagliflozin treatment. β-Hydroxybutyrate increased with dapagliflozin treatment in the residual native kidney group, while a small increase was observed only at 360 min in the nephrectomy group. Plasma adrenaline (epinephrine) did not change after dapagliflozin and placebo treatment in either group. Following dapagliflozin administration, plasma noradrenaline (norepinephrine) increased slightly in the residual native kidney group and decreased in the nephrectomy group. In nephrectomised individuals, the hepatic compensatory response to acute SGLT2 inhibitor-induced glucosuria was attenuated, as compared with individuals with residual native kidneys, suggesting that SGLT2 inhibitor-mediated stimulation of hepatic glucose production via efferent renal nerves occurs in an attempt to compensate for the urinary glucose loss (i.e. a renal–hepatic axis). ClinicalTrials.gov NCT03168295 This protocol was supported by Qatar National Research Fund (QNRF) Award No. NPRP 8-311-3-062 and NIH grant DK024092-38. Graphical abstract
Tài liệu tham khảo
citation_journal_title=J Clin Invest; citation_title=Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production; citation_author=A Merovci, C Solis-Herrera, G Daniele; citation_volume=124; citation_issue=2; citation_publication_date=2014; citation_pages=509-514; citation_doi=10.1172/JCI70704; citation_id=CR1
citation_journal_title=J Clin Invest; citation_title=Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients; citation_author=E Ferrannini, E Muscelli, S Frascerra; citation_volume=124; citation_issue=2; citation_publication_date=2014; citation_pages=499-508; citation_doi=10.1172/JCI72227; citation_id=CR2
citation_journal_title=Diabetes; citation_title=Empagliflozin and kinetics of renal glucose transport in healthy individuals and individuals with type 2 diabetes; citation_author=H Jobori, G Daniele, E Cersosimo; citation_volume=66; citation_issue=7; citation_publication_date=2017; citation_pages=1999-2006; citation_doi=10.2337/db17-0100; citation_id=CR3
citation_journal_title=Circulation; citation_title=Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study; citation_author=F Mahfoud, M Schlaich, I Kindermann; citation_volume=123; citation_issue=18; citation_publication_date=2011; citation_pages=1940-1946; citation_doi=10.1161/CIRCULATIONAHA.110.991869; citation_id=CR4
citation_journal_title=Front Physio; citation_title=Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension; citation_author=MP Schlaich, D Hering, P Sobotka; citation_volume=3; citation_publication_date=2012; citation_pages=10; citation_doi=10.3389/fphys.2012.00010; citation_id=CR5
citation_journal_title=Diabetes Care; citation_title=Increase in endogenous glucose production with SGLT2 inhibition is unchanged by renal denervation and correlates strongly with the increase in urinary glucose excretion; citation_author=C Solis-Herrea, G Daniele, M Alatrach; citation_volume=43; citation_issue=5; citation_publication_date=2020; citation_pages=1065-1069; citation_doi=10.2337/dc19-2177; citation_id=CR6
citation_journal_title=Comput Methods Prog Biomed; citation_title=A circulatory model for calculating non-steady-state glucose fluxes. Validation and comparison with compartmental models; citation_author=A Mari, L Stojanovska, J Proietto, AW Thorburn; citation_volume=71; citation_issue=3; citation_publication_date=2003; citation_pages=269-281; citation_doi=10.1016/s0169-2607(02)00097-4; citation_id=CR7
citation_journal_title=Am J Physiol Endocrinol Metab; citation_title=Dose-response characteristics of insulin action on glucose metabolism: a nonsteady-state approach; citation_author=A Natali, A Gastaldelli, S Camastra; citation_volume=278; citation_issue=5; citation_publication_date=2000; citation_pages=E794-E801; citation_doi=10.1152/ajpendo.2000.278.5.E794; citation_id=CR8
citation_journal_title=Am J Physiol Endocrinol Metab; citation_title=Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms; citation_author=S Bonuccelli, E Muscelli, A Gastaldelli; citation_volume=297; citation_issue=2; citation_publication_date=2009; citation_pages=E532-E537; citation_doi=10.1152/ajpendo.00127.2009; citation_id=CR9
citation_journal_title=Diabetes Care; citation_title=Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study; citation_author=D Polidori, S Sha, S Sunder Mudaliar; citation_volume=36; citation_issue=8; citation_publication_date=2013; citation_pages=2154-2161; citation_doi=10.2337/dc12-2391; citation_id=CR10
citation_journal_title=Am J Phys; citation_title=Indirect calorimetry: methodological and interpretative problems; citation_author=DC Simonson, RA DeFronzo; citation_volume=258; citation_issue=3; citation_publication_date=1990; citation_pages=E399-E412; citation_doi=10.1152/ajpendo.1990.258.3.E399; citation_id=CR11
citation_journal_title=Metabolism; citation_title=The theoretical bases of indirect calorimetry: a review; citation_author=E Ferrannini; citation_volume=37; citation_issue=3; citation_publication_date=1988; citation_pages=287-301; citation_doi=10.1016/0026-0495(88)90110-2; citation_id=CR12
citation_journal_title=Clin J Am Soc Nephrol; citation_title=Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target; citation_author=R Santer, J Calado; citation_volume=5; citation_issue=1; citation_publication_date=2010; citation_pages=133-141; citation_doi=10.2215/CJN.04010609; citation_id=CR13
citation_journal_title=Diabetes Obes Metab; citation_title=The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia; citation_author=RA DeFronzo, JA Davidson, S Prato; citation_volume=14; citation_issue=1; citation_publication_date=2012; citation_pages=5-14; citation_doi=10.1111/j.1463-1326.2011.01511.x; citation_id=CR14
citation_journal_title=Clin Auton Res; citation_title=Catecholamines 101; citation_author=DS Goldstein; citation_volume=20; citation_issue=6; citation_publication_date=2010; citation_pages=331-352; citation_doi=10.1007/s10286-010-0065-7; citation_id=CR15
citation_journal_title=Transplant Proc; citation_title=Native kidney function after renal combined with other solid organs in preemptive patients; citation_author=G Mosconi, L Panicali, E Persici; citation_volume=42; citation_issue=4; citation_publication_date=2010; citation_pages=1017-1020; citation_doi=10.1016/j.transproceed.2010.03.125; citation_id=CR16
citation_journal_title=Transplantation; citation_title=Contribution of native kidney function to total glomerular filtration rate after combined kidney-pancreas transplantation; citation_author=M Pascual, CA Rabito, N Tolkoff-Rubin; citation_volume=65; citation_issue=1; citation_publication_date=1998; citation_pages=99-103; citation_doi=10.1097/00007890-199801150-00019; citation_id=CR17
citation_journal_title=Diabetologia; citation_title=Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats; citation_author=K Rafiq, Y Fujisawa, SJ Sherajee; citation_volume=58; citation_issue=12; citation_publication_date=2015; citation_pages=2885-2898; citation_doi=10.1007/s00125-015-3771-9; citation_id=CR18
citation_journal_title=Mol Metab; citation_title=Reduced renal sympathetic nerve activity contributes to elevated glycosuria and improved glucose tolerance in hypothalamus-specific Pomc knockout mice; citation_author=KH Chhabra, DA Morgan, BP Tooke, JM Adams, K Rahmouni, MJ Low; citation_volume=6; citation_issue=10; citation_publication_date=2017; citation_pages=1274-1285; citation_doi=10.1016/j.molmet.2017.07.005; citation_id=CR19
citation_journal_title=Diabetologia; citation_title=The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure; citation_author=MC Thomas, DZI Cherney; citation_volume=61; citation_issue=10; citation_publication_date=2018; citation_pages=2098-2107; citation_doi=10.1007/s00125-018-4669-0; citation_id=CR20
citation_journal_title=Nat Med; citation_title=Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion; citation_author=C Bonner, J Kerr-Conte, V Gmyr; citation_volume=21; citation_issue=5; citation_publication_date=2015; citation_pages=512-517; citation_doi=10.1038/nm.3828; citation_id=CR21
citation_journal_title=Diabetologia; citation_title=No direct effect of SGLT2 activity on glucagon secretion; citation_author=RE Kuhre, SM Ghiasi, AE Adriaenssens; citation_volume=62; citation_issue=6; citation_publication_date=2019; citation_pages=1011-1023; citation_doi=10.1007/s00125-019-4849-6; citation_id=CR22
citation_journal_title=Diabetes; citation_title=Endogenous glucose production and hormonal changes in response to canagliflozin and liraglutide combination therapy; citation_author=R Martinez, H Al-Jobori, AM Ali; citation_volume=67; citation_issue=6; citation_publication_date=2018; citation_pages=1182-1189; citation_doi=10.2337/db17-1278; citation_id=CR23
citation_journal_title=Diabetes Care; citation_title=Dapagliflozin enhances fat oxidation and ketone production in patients with type 2 diabetes; citation_author=G Daniele, J Xiong, C Solis-Herrera; citation_volume=39; citation_issue=11; citation_publication_date=2016; citation_pages=2036-2041; citation_doi=10.2337/dc15-2688; citation_id=CR24
citation_journal_title=J Clin Invest; citation_title=Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon; citation_author=J McGarry, PH Wright, DW Foster; citation_volume=55; citation_issue=6; citation_publication_date=1975; citation_pages=1202-1209; citation_doi=10.1172/JCI108038; citation_id=CR25
citation_journal_title=Diabetes Obes Metab; citation_title=Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients; citation_author=H Jobori, G Daniele, J Adams; citation_volume=19; citation_issue=6; citation_publication_date=2017; citation_pages=809-813; citation_doi=10.1111/dom.12881; citation_id=CR26
citation_journal_title=PLoS One; citation_title=The prevalence of autosomal dominant polycystic kidney disease (ADPKD): a meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition; citation_author=A Solazzo, F Testa, S Giovanella; citation_volume=13; citation_issue=1; citation_publication_date=2018; citation_pages=e0190430; citation_doi=10.1371/journal.pone.0190430; citation_id=CR27